Hybrid Techniques Combining Hypofractionated Whole Breast Radiotherapy With Concomitant Tumor Bed Boost in Patients With Breast Cancer
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Radiation
Study Type: Observational
SUMMARY
Hypofractionated breast radiotherapy with concomitant tumor bed boost for early breast cancer or ductal breast carcinoma in situ after partial mastectomy
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 20
Maximum Age: 85
Healthy Volunteers: f
View:
• Female patients with histologically confirmed early-stage breast cancer (T1-2 and N0-1) or ductal carcinoma in situ (DCIS).
• Patients undergoing breast-conserving surgery
• Age ≥ 20 years
• Karnofsky Performance Status (KPS) ≥70%
• Life expectancy ≥ 5 years
• Adequate renal and hepatic function
Locations
Other Locations
Taiwan
National Taiwan University Hospital
NOT_YET_RECRUITING
Taipei
National Taiwan University Hospital Yunlin Branch
RECRUITING
Taipei
Contact Information
Primary
Yen-Ting Liu
nickliucool@ntuh.gov.tw
88697255451
Time Frame
Start Date: 2025-02-06
Estimated Completion Date: 2030-02-28
Participants
Target number of participants: 315
Treatments
CBB
Hypofractionated breast radiotherapy following partial mastectomy in patients with early breast cancer or ductal breast carcinoma in situ
Related Therapeutic Areas
Sponsors
Leads: National Taiwan University Hospital